Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Long noncoding RNA SAMMSON promotes papillary thyroid carcinoma progression through p300/Sp1 axis and serves as a novel diagnostic and prognostic biomarker.

Shao L, Sun W, Wang Z, Dong W, Qin Y.

IUBMB Life. 2019 Sep 3. doi: 10.1002/iub.2158. [Epub ahead of print]

PMID:
31478331
2.

Long noncoding RNA HIT000218960 promotes papillary thyroid cancer oncogenesis and tumor progression by upregulating the expression of high mobility group AT-hook 2 (HMGA2) gene.

Li T, Yang XD, Ye CX, Shen ZL, Yang Y, Wang B, Guo P, Gao ZD, Ye YJ, Jiang KW, Wang S.

Cell Cycle. 2017 Jan 17;16(2):224-231. doi: 10.1080/15384101.2016.1261768. Epub 2016 Dec 8.

3.

LncRNA HOTTIP promotes papillary thyroid carcinoma cell proliferation, invasion and migration by regulating miR-637.

Yuan Q, Liu Y, Fan Y, Liu Z, Wang X, Jia M, Geng Z, Zhang J, Lu X.

Int J Biochem Cell Biol. 2018 May;98:1-9. doi: 10.1016/j.biocel.2018.02.013. Epub 2018 Feb 21.

PMID:
29474928
4.

A novel lncRNA n384546 promotes thyroid papillary cancer progression and metastasis by acting as a competing endogenous RNA of miR-145-5p to regulate AKT3.

Feng J, Zhou Q, Yi H, Ma S, Li D, Xu Y, Wang J, Yin S.

Cell Death Dis. 2019 Jun 3;10(6):433. doi: 10.1038/s41419-019-1637-7.

5.

STAT3-induced upregulation of lncRNA ABHD11-AS1 promotes tumour progression in papillary thyroid carcinoma by regulating miR-1301-3p/STAT3 axis and PI3K/AKT signalling pathway.

Wen J, Wang H, Dong T, Gan P, Fang H, Wu S, Li J, Zhang Y, Du R, Zhu Q.

Cell Prolif. 2019 Mar;52(2):e12569. doi: 10.1111/cpr.12569. Epub 2019 Jan 18.

PMID:
30657221
6.

The expression and function of long noncoding RNA lncRNA-ATB in papillary thyroid cancer.

Fu XM, Guo W, Li N, Liu HZ, Liu J, Qiu SQ, Zhang Q, Wang LC, Li F, Li CL.

Eur Rev Med Pharmacol Sci. 2017 Jul;21(14):3239-3246.

7.

Long non‑coding RNA UCA1 promotes papillary thyroid cancer cell proliferation via miR‑204‑mediated BRD4 activation.

Li D, Cui C, Chen J, Hu Z, Wang Y, Hu D.

Mol Med Rep. 2018 Sep;18(3):3059-3067. doi: 10.3892/mmr.2018.9246. Epub 2018 Jul 3.

PMID:
30015945
8.

LncRNA SNHG12 promotes the proliferation and metastasis of papillary thyroid carcinoma cells through regulating wnt/β-catenin signaling pathway.

Ding S, Qu W, Jiao Y, Zhang J, Zhang C, Dang S.

Cancer Biomark. 2018;22(2):217-226. doi: 10.3233/CBM-170777.

PMID:
29630517
9.

Upregulation of lncRNA-ATB by Transforming Growth Factor β1 (TGF-β1) Promotes Migration and Invasion of Papillary Thyroid Carcinoma Cells.

Cui M, Chang Y, Du W, Liu S, Qi J, Luo R, Luo S.

Med Sci Monit. 2018 Jul 25;24:5152-5158. doi: 10.12659/MSM.909420.

10.

Long noncoding RNA H19 is a critical oncogenic driver and contributes to epithelial-mesenchymal transition in papillary thyroid carcinoma.

Liang WQ, Zeng, Chen CF, Sun SM, Lu XF, Peng CY, Lin HY.

Cancer Manag Res. 2019 Mar 6;11:2059-2072. doi: 10.2147/CMAR.S195906. eCollection 2019.

11.

SP1-induced upregulation of long noncoding RNA LINC00313 contributes to papillary thyroid cancer progression via the miR-422a.

Yan DG, Liu N, Chao M, Tu YY, Liu WS.

Eur Rev Med Pharmacol Sci. 2019 Feb;23(3):1134-1144. doi: 10.26355/eurrev_201902_17004.

12.

Overexpression of long non-coding RNA NR_036575.1 contributes to the proliferation and migration of papillary thyroid cancer.

Sun W, Lan X, Wang Z, Dong W, He L, Zhang T, Zhang H.

Med Oncol. 2016 Sep;33(9):102. doi: 10.1007/s12032-016-0816-y. Epub 2016 Aug 10.

PMID:
27510368
13.

Long noncoding RNA small nucleolar RNA host gene 12 promotes papillary thyroid carcinoma cell growth and invasion by targeting miR-16-5p.

Feng X, Dong X, Wu D, Zhao H, Xu C, Li H.

Histol Histopathol. 2019 Jul 29:18155. doi: 10.14670/HH-18-155. [Epub ahead of print]

PMID:
31355416
14.

DNA copy number gain-mediated lncRNA LINC01061 upregulation predicts poor prognosis and promotes papillary thyroid cancer progression.

Wu X, Yan Y, Li H, Ji N, Yu T, Huang Y, Shi W, Gao L, Ma L, Hu Y.

Biochem Biophys Res Commun. 2018 Sep 10;503(3):1247-1253. doi: 10.1016/j.bbrc.2018.07.032. Epub 2018 Jul 11.

PMID:
30029886
15.

Expression and Function of Long Noncoding RNA NONHSAT129183 in Papillary Thyroid Cancer.

Ding J, Wang F, Xiang T, Qiao M.

Oncol Res. 2018 Aug 23;26(7):1047-1053. doi: 10.3727/096504018X15152037713570. Epub 2018 Jan 10.

PMID:
29321094
16.

Long noncoding RNA ABHD11-AS1 functions as a competing endogenous RNA to regulate papillary thyroid cancer progression by miR-199a-5p/SLC1A5 axis.

Zhuang X, Tong H, Ding Y, Wu L, Cai J, Si Y, Zhang H, Shen M.

Cell Death Dis. 2019 Aug 14;10(8):620. doi: 10.1038/s41419-019-1850-4.

17.

Long noncoding RNA LINC00460 promotes carcinogenesis via sponging miR-613 in papillary thyroid carcinoma.

Feng L, Yang B, Tang XD.

J Cell Physiol. 2019 Jul;234(7):11431-11439. doi: 10.1002/jcp.27799. Epub 2018 Nov 27.

PMID:
30478856
18.

LncRNA CASC2 expression is down- regulated in papillary thyroid cancer and promotes cell invasion by affecting EMT pathway.

Zhou T, Zhong M, Zhang S, Wang Z, Xie R, Xiong C, Lv Y, Chen W, Yu J.

Cancer Biomark. 2018;23(2):185-191. doi: 10.3233/CBM-181198. Erratum in: Cancer Biomark. 2019;25(3):293.

PMID:
30175973
19.

LncRNA SAMMSON overexpression distinguished glioblastoma patients from patients with diffuse neurosarcoidosis.

Xie J, Wang X, Liu S, Chen C, Jiang F, Mao K, Zeng F.

Neuroreport. 2019 Aug 14;30(12):817-821. doi: 10.1097/WNR.0000000000001278.

PMID:
31283714
20.

LncRNA NORAD promotes thyroid carcinoma progression through targeting miR-202-5p.

He H, Yang H, Liu D, Pei R.

Am J Transl Res. 2019 Jan 15;11(1):290-299. eCollection 2019.

Supplemental Content

Support Center